Mechanisms of allergen specific immunotherapy--T-cell tolerance and more.
about
Induction of tolerance via the sublingual route: mechanisms and applicationsTargeting allergen to Fc gammaRI: a strategy to treat allergic disease?Nature of regulatory T cells in the context of allergic disease.Type 2 immune-inducing helminth vaccination maintains protective efficacy in the setting of repeated parasite exposures.Control and regulation of peripheral tolerance in allergic inflammatory disease: therapeutic consequences100 years of hyposensitization: history of allergen-specific immunotherapy (ASIT).Hymenoptera venom immunotherapy.Mechanisms of immunotherapy to wasp and bee venom.Specific immunotherapy in children: the evidence.Immunotherapy of type-1 allergies with virus-like particles and CpG-motifs.Gene expression analysis predicts insect venom anaphylaxis in indolent systemic mastocytosis.Early gene expression changes with rush immunotherapy.Carbohydrate-based particles reduce allergic inflammation in a mouse model for cat allergy.Dermatophagoides pteronyssinus immunotherapy changes the T-regulatory cell activity.Sublingual immunotherapy in allergic asthma: Current evidence and needs to meet.Difference in symptom severity between early and late grass pollen season in patients with seasonal allergic rhinitis.Are we getting enough allergens?Lower risk of atopic dermatitis among infants born extremely preterm compared with higher gestational age.Oral immunotherapy with transgenic rice seed containing destructed Japanese cedar pollen allergens, Cry j 1 and Cry j 2, against Japanese cedar pollinosis.[Immunotherapy of allergic rhinitis without allergens? : new options for immunomodulation by vaccination with virus-like particles and CpG motifs].Analysis of safety, risk factors and pretreatment methods during rush hymenoptera venom immunotherapy.Unique and cross-reactive T cell epitope peptides of the major Bahia grass pollen allergen, Pas n 1.Conformational IgE Epitope Mapping of Der p 2 and the Evaluations of Two Candidate Hypoallergens for Immunotherapy.Tolerance induction after specific immunotherapy with pollen allergoids adjuvanted by monophosphoryl lipid A in children.Selective blockade of NF-kappaB by novel mutated IkappaBalpha suppresses CD3/CD28-induced activation of memory CD4+ T cells in asthma.The role of regulatory T cells and genes involved in their differentiation in pathogenesis of selected inflammatory and neoplastic skin diseases. Part II: The Treg role in skin diseases pathogenesis.Induced pluripotent stem cell-derived mesenchymal stem cells activate quiescent T cells and elevate regulatory T cell response via NF-κB in allergic rhinitis patients.Comparison between major histocompatibility complex class II tetramer staining and surface expression of activation markers for the detection of allergen-specific CD4+ T cellsAllergen-specific immunotherapy for allergic rhinitis in the elderly: is it never too late?
P2860
Q27022140-C409FD52-A3DA-48BB-AC31-70550F829E1FQ30437725-F75B076A-BDD8-4924-AAD9-B381F6F708F9Q33846653-B7583813-50DB-4D2B-8196-170CB8F53520Q35111535-6D48510D-F809-4E06-A173-24EA8F915AC3Q37273165-32456F36-0EF1-440F-AFC4-6C83431F55D1Q37841682-11C7C8FE-FBEC-40D8-B710-F6314A0DBE8AQ37842330-9330D13E-E486-4E64-821D-750581905894Q37897667-96B20A39-9553-4134-B9F2-04A19D742FA8Q37950136-06E71399-66D6-45B8-8D3F-5ACDA2473FE6Q38217708-7A56B71E-877B-49E2-84B0-5E4423BB7906Q38504083-2DE20CBA-E2CE-4091-BFAC-FAD57BDCF11DQ38736789-ED036342-DF90-436B-88C7-7A5E2C93889AQ39321330-2040372D-0A85-471B-B160-D9EB94A2F3B9Q41697162-072D30BF-A2E8-486A-8074-138013474BBDQ42056866-58AEA050-1607-47BE-AB3C-12106041C3DBQ42140036-F292EA5A-BC4A-4367-A040-E5F1C1E320DEQ42957911-39DD6775-10DC-458E-9513-386F0292C7CDQ43486263-FAC555E6-5216-46DE-984B-A191F0E33CF5Q43560444-099DF5A6-E1C7-44DC-95C3-BE8533F899B3Q43962396-B20D3B71-B506-4DDB-9BD1-57A523DB0149Q46507238-EB934D2F-3CD0-43EE-9269-5A53C18EF164Q46640921-5AB5FB8D-26EC-4452-ACC4-E33A73EDA9D9Q50358296-14EAD880-E4E4-4BED-BDC1-6F23E9595070Q51575029-20222A33-195B-4E3C-B025-93C8F6C48050Q51968876-85C07E9D-C1C7-4EFF-A212-612B8675F19FQ54261770-B47213CA-44EC-4EB7-BE15-D10F31A2D08EQ55345249-3E7B41BB-CA1B-40D9-9BBB-E9074EAF67D4Q58617157-FBE571DD-4853-48ED-9D46-3AFA77756131Q58823375-E328E8D7-851A-4912-BCF7-5CD5B06F43D4
P2860
Mechanisms of allergen specific immunotherapy--T-cell tolerance and more.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Mechanisms of allergen specific immunotherapy--T-cell tolerance and more.
@ast
Mechanisms of allergen specific immunotherapy--T-cell tolerance and more.
@en
type
label
Mechanisms of allergen specific immunotherapy--T-cell tolerance and more.
@ast
Mechanisms of allergen specific immunotherapy--T-cell tolerance and more.
@en
prefLabel
Mechanisms of allergen specific immunotherapy--T-cell tolerance and more.
@ast
Mechanisms of allergen specific immunotherapy--T-cell tolerance and more.
@en
P2093
P2860
P1433
P1476
Mechanisms of allergen specific immunotherapy--T-cell tolerance and more.
@en
P2093
P2860
P304
P356
10.1111/J.1398-9995.2006.01175.X
P50
P577
2006-07-01T00:00:00Z